ML20127A287
| ML20127A287 | |
| Person / Time | |
|---|---|
| Issue date: | 01/05/1993 |
| From: | Rogers K NRC COMMISSION (OCM) |
| To: | Marcus C CALIFORNIA, UNIV. OF, LOS ANGELES, CA |
| Shared Package | |
| ML20127A292 | List: |
| References | |
| NUDOCS 9301110241 | |
| Download: ML20127A287 (2) | |
Text
h, f\\
pu%q\\
I
/
UNITED STATES
% N-D
[^
g NUCLEAR REGULATORY COMMISSION y
W ASHINGTON, D. C. 20555
.d CHAIRMAN January 5, 1993 Carol S.
- Marcus, Ph.D.,
M.D.
Director, Nuclear Medicine Outpatient Clinic and Associate Professor of Radiological Sciences University of California, Los Angeles 1000 Carson Street Tortance, California 90509
Dear Dr. Marcus:
I am responding to your letter of December 22, 1992, to Chairman Selin.
He is on foreign travel.
The NRC staff is carefully reviewing the regulatory issues raised in the Cleveland Plain Dealer series.
The Commission believes that it is especially important that particular attention be paid in this review to the identification and correction of factual errors, as well as to the identification of those matters where the Plain Dealer series points to the need for the agency to evaluate the adequacy of the regulatory approach that we have taken in this area.
The Commission as a matter of policy will not participate in a response to-the regulatory issues raised in the Cleveland Plain Dcaler series with a group representing its licensees.
Chairman Selin has written to the Elain Dealer, and we anticipate that once the Commission has had an opportunity to consider our staff's assessment, there will be a number of ether occasions to consider what further actions might be appropriate.
In this regard, the Commission has scheduled a public briefing by the staff on January 22, 1993, to discuss medical licensing matters.
That meeting will provide an opportunity for the Commission to examine a wide range of issues related to our regulatory program in the medical arena, including many of the issues that you raised in your letter.
Also scheduled are a public' briefing to the Commissioners on January 29 by Agreement States on their regulation of medical use of byproduct material, a congressional hearing on February 2 on NRC regulation of medical uses, and a public briefing for the Commissioners on February 8 by the NRC staff team which investigated the two recent Oncology Services incidents in Pennsylvania.
In late February, the Commission 080059 I
d)@U
^
9301110241 930105 PDR COMMS NRCC g'.
CORRESPONDENCE PDR
(
</
2 expects a-public. briefing by the staff on-a proposed-radiopharmacy rulemaking to address the petition' filed by the American College of Nuclear Physicians and the' Society for Nuclear Medicine.
Sincerely, i
l
'ML n
O Kenneth C. Rogers Acting Chairman
.___-_______.u-.
-